
Todd W. Frieze, MD, concludes this series discussing differences in benign vs cancerous tumors and key final takeaways.
Todd W. Frieze, MD, concludes this series discussing differences in benign vs cancerous tumors and key final takeaways.
Todd W. Frieze, MD, highlights the various ways to accurately assess patient thyroid hormone levels and the general guidelines on patient surveillance.
Todd W. Frieze, MD, discusses various suppression therapy approaches for patients with hypothyroidism and thyroid cancer.
Todd W. Frieze, MD, discusses the therapeutic role of TSH suppression in differentiated thyroid cancer, as well as treatment goals and ongoing surveillance strategies.
Published: December 24th 2024 | Updated: